IMCIVREE

Serial Number 90178986
Registration 6413125
700

Registration Progress

Application Filed
Sep 14, 2020
Under Examination
Apr 27, 2021
Approved for Publication
Mar 2, 2021
Published for Opposition
Mar 2, 2021
Registered
Jul 6, 2021

Trademark Image

IMCIVREE

Basic Information

Serial Number
90178986
Registration Number
6413125
Filing Date
September 14, 2020
Registration Date
July 6, 2021
Published for Opposition
March 2, 2021
Drawing Code
3

Status Summary

Current Status
Active
Status Code
700
Status Date
Jul 6, 2021
Registration
Registered
Classes
005

Rights Holder

Rhythm Pharmaceuticals, Inc.

03
Address
222 Berkeley Street, Suite 1200
BOSTON, MA 02116

Ownership History

Rhythm Pharmaceuticals, Inc.

Original Applicant
03
Boston, MA

Rhythm Pharmaceuticals, Inc.

Owner at Publication
03
Boston, MA

Rhythm Pharmaceuticals, Inc.

Original Registrant
03
BOSTON, MA

Legal Representation

Attorney
Peter G. Byrne, Esq.

USPTO Deadlines

Next Deadline
704 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2021-07-06)
Due Date
July 06, 2027
Grace Period Ends
January 06, 2028
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

26 events
Date Code Type Description Documents
Jun 20, 2024 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Loading...
Jun 20, 2024 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Jun 20, 2024 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Jun 20, 2024 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jun 20, 2024 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Jun 20, 2024 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Feb 16, 2022 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Loading...
Feb 16, 2022 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Feb 16, 2022 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Feb 16, 2022 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Jul 6, 2021 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jun 3, 2021 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Jun 2, 2021 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
May 29, 2021 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
May 29, 2021 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
May 18, 2021 IUAF S USE AMENDMENT FILED Loading...
May 18, 2021 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Apr 27, 2021 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Mar 2, 2021 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Mar 2, 2021 PUBO A PUBLISHED FOR OPPOSITION Loading...
Feb 10, 2021 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jan 28, 2021 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jan 26, 2021 DOCK D ASSIGNED TO EXAMINER Loading...
Oct 22, 2020 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Oct 21, 2020 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Sep 17, 2020 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceuticals and medicines for the treatment of obesity and metabolic diseases and disorders
First Use Anywhere: Mar 1, 2021
First Use in Commerce: Mar 1, 2021

Additional Information

Design Mark
The mark consists of the word IMCIVREE; immediately above and nested within the letter "V" in that word is a smaller stylized letter "V", immediately above which is nested a raised stylized diamond design.

Classification

International Classes
005